Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia--a review.
Clowes
A W
AW
Department of Surgery, University of Washington School of Medicine, Seattle 98195.
Reidy
M A
MA
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D003251:Constriction, Pathologic / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000473:pathology*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006965:Hyperplasia; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D014945:Wound Healing / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D006493:Heparin